Revolution Medicines, Beta vs. Total Asset
| RVMDW Stock | 0.32 0 1.00% |
For Revolution Medicines, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Revolution Medicines, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Revolution Medicines, Warrant utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Revolution Medicines,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Revolution Medicines, Warrant over time as well as its relative position and ranking within its peers.
Revolution |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines,. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.005 | Return On Assets (0.29) | Return On Equity (0.47) |
The market value of Revolution Medicines, is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines,'s value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines,'s market value can be influenced by many factors that don't directly affect Revolution Medicines,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Revolution Medicines, Total Asset vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Revolution Medicines,'s current stock value. Our valuation model uses many indicators to compare Revolution Medicines, value to that of its competitors to determine the firm's financial worth. Revolution Medicines, Warrant is currently regarded as top stock in beta category among its peers. It also is currently regarded as top stock in total asset category among its peers fabricating about 1,468,450,855 of Total Asset per Beta. At this time, Revolution Medicines,'s Total Assets are fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Revolution Medicines, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Revolution Total Asset vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Revolution Medicines, |
| = | 1.4 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Revolution Medicines, |
| = | 2.06 B |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Revolution Total Asset Comparison
Revolution Medicines, is currently under evaluation in total asset category among its peers.
Beta Analysis
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revolution Medicines, will likely underperform.
Revolution Medicines, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Revolution Medicines,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Revolution Medicines, will eventually generate negative long term returns. The profitability progress is the general direction of Revolution Medicines,'s change in net profit over the period of time. It can combine multiple indicators of Revolution Medicines,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 544 K | 571.2 K | |
| Net Interest Income | 47.2 M | 49.5 M | |
| Interest Income | 47.5 M | 49.9 M | |
| Operating Income | -487.2 M | -462.8 M | |
| Net Loss | -436.4 M | -414.5 M | |
| Income Before Tax | -439.9 M | -417.9 M | |
| Net Loss | -436.4 M | -414.5 M | |
| Total Other Income Expense Net | 47.3 M | 49.7 M | |
| Income Tax Expense | -3.5 M | -3.7 M | |
| Net Loss | (3.86) | (4.05) | |
| Income Quality | 0.80 | 0.60 | |
| Net Income Per E B T | 0.99 | 0.78 |
Revolution Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Revolution Medicines,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Revolution Medicines, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Revolution Medicines,'s important profitability drivers and their relationship over time.
Use Revolution Medicines, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Revolution Medicines, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines, will appreciate offsetting losses from the drop in the long position's value.Revolution Medicines, Pair Trading
Revolution Medicines, Warrant Pair Trading Analysis
The ability to find closely correlated positions to Revolution Medicines, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Revolution Medicines, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Revolution Medicines, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Revolution Medicines, Warrant to buy it.
The correlation of Revolution Medicines, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Revolution Medicines, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Revolution Medicines, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Revolution Medicines, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Revolution Medicines, position
In addition to having Revolution Medicines, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.